Evaluation of Hepatitis B and C Reactivation in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors. Mediterr J Hematol Infect Dis 2026, 18 (1), e2026001. https://doi.org/10.4084/MJHID.2026.001.